Delivering nanomedicine to solid tumors
نویسندگان
چکیده
منابع مشابه
Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening
The increasing number of publications on the subject shows that nanomedicine is an attractive field for investigations aiming to considerably improve anticancer chemotherapy. Based on selective tumor targeting while sparing healthy tissue, carrier-mediated drug delivery has been expected to provide significant benefits to patients. However, despite reduced systemic toxicity, most nanodrugs appr...
متن کاملIntracavitary radioimmunotherapy to treat solid tumors.
Radioimmunotherapy (RIT) potentially is an attractive treatment for radiosensitive early-stage solid tumors and as an adjuvant to cytoreductive surgery. Topical administration of RIT may improve the efficacy because higher local concentrations are achieved. We reviewed the results of locally applied radiolabeled monoclonal antibodies for the treatment of solid tumors. Intracavitary RIT in patie...
متن کاملBarriers to drug delivery in solid tumors
Over the last decade, significant progress has been made in the field of drug delivery. The advent of engineered nanoparticles has allowed us to circumvent the initial limitations to drug delivery such as pharmacokinetics and solubility. However, in spite of significant advances to tumor targeting, an effective treatment strategy for malignant tumors still remains elusive. Tumors possess distin...
متن کاملSymposium on Solid Tumors
Malignant melanoma Is an a^resslve, therapy-resistant malignancy of melanocytes. The incidence of meianoma has l>een steadily increasing worldwide, resulting In an increasing pubiic health problem. Exposure to solar UV radiation, fair skin, dysplastlc nevi syndrome, and a family history of meianoma are major risk factors for melanoma development. The interactions between genetic and environment...
متن کاملSolid Tumors: a Review
The therapeutics of tumor is largely confined upon directly encountering the tumor cells. The current cytostatic agents mainly interfere with processes involved in cell growth while the aim in immunotherapy is to make immune effector cells to selectively attack the tumor cells. A recent approach to fight tumor is to impede and interfere with its blood supply, i.e., turning off angiogenesis or n...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2010
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2010.139